Some Are Considering It Yale New Haven Health: Should You Suddenly Stop Taking GLP-1s
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward to minimize gastrointestinal side effects
But lets dig into a bit more research here
While it technically belongs to a class of peptides called ghrelin mimetics, it is a third-generation peptide
They started with body composition, gave me the option to run labs (recommend doing them), and built the protocol around what my body actually needed
However, in some patients taking GLP-1 medications, specialists have noticed benign, physiological patterns mainly involving the stomach, bowel, muscle, and fat rather than signs of disease or damage